Endocrine disruption of vitamin D activity by perfluoro-octanoic acid (PFOA)

[1]  L. Rylander,et al.  Intrauterine exposure to perfluorinated compounds and overweight at age 4: A case-control study , 2020, PloS one.

[2]  L. Liang,et al.  Perfluoroalkyl substances and changes in bone mineral density: A prospective analysis in the POUNDS-LOST study. , 2019, Environmental research.

[3]  J. Bergquist,et al.  Effects of glucocorticoids on vitamin D3-metabolizing 24-hydroxylase (CYP24A1) in Saos-2 cells and primary human osteoblasts , 2019, Molecular and Cellular Endocrinology.

[4]  D. Guidolin,et al.  Perfluoroalkyl substances and bone health in young men: a pilot study , 2019, Endocrine.

[5]  D. Guidolin,et al.  Endocrine Disruption of Androgenic Activity by Perfluoroalkyl Substances: Clinical and Experimental Evidence , 2018, The Journal of clinical endocrinology and metabolism.

[6]  T. Etzel,et al.  Associations of serum perfluoroalkyl substance and vitamin D biomarker concentrations in NHANES, 2003-2010. , 2019, International journal of hygiene and environmental health.

[7]  K. Northstone,et al.  Prenatal concentrations of perfluoroalkyl substances and bone health in British girls at age 17 , 2018, Archives of Osteoporosis.

[8]  Yeonhwa Park,et al.  Perfluorobutanesulfonic acid (PFBS) potentiates adipogenesis of 3T3-L1 adipocytes. , 2018, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[9]  Mateusz Kurcinski,et al.  CABS-flex 2.0: a web server for fast simulations of flexibility of protein structures , 2018, Nucleic Acids Res..

[10]  Ramzi W. Nahhas,et al.  Perfluoroalkyl substances, bone density, and cardio‐metabolic risk factors in obese 8–12 year old children: A pilot study , 2018, Environmental research.

[11]  Chien-Yu Lin,et al.  Association among total serum isomers of perfluorinated chemicals, glucose homeostasis, lipid profiles, serum protein and metabolic syndrome in adults: NHANES, 2013-2014. , 2018, Environmental pollution.

[12]  S. Tescari,et al.  Impact of perfluorochemicals on human health and reproduction: a male’s perspective , 2018, Journal of Endocrinological Investigation.

[13]  Irina S. Moreira,et al.  Performance of HADDOCK and a simple contact-based protein–ligand binding affinity predictor in the D3R Grand Challenge 2 , 2017, Journal of Computer-Aided Molecular Design.

[14]  J. Meeker,et al.  Urinary BPA and Phthalate Metabolite Concentrations and Plasma Vitamin D Levels in Pregnant Women: A Repeated Measures Analysis , 2017, Environmental health perspectives.

[15]  P. Lehenkari,et al.  Perfluoroalkyl substances in human bone: concentrations in bones and effects on bone cell differentiation , 2017, Scientific Reports.

[16]  Kyungho Choi,et al.  Perfluoroalkyl substances exposure and thyroid hormones in humans: epidemiological observations and implications , 2017, Annals of pediatric endocrinology & metabolism.

[17]  M. Lopez-Espinosa,et al.  Exposure to perfluoroalkyl substances and thyroid function in pregnant women and children: A systematic review of epidemiologic studies. , 2017, Environment international.

[18]  T. Mitsui,et al.  The Association of Prenatal Exposure to Perfluorinated Chemicals with Glucocorticoid and Androgenic Hormones in Cord Blood Samples: The Hokkaido Study , 2016, Environmental health perspectives.

[19]  D. Brenner,et al.  The role of DNA repair capacity in lung cancer risk among never-smokers: A systematic review of epidemiologic studies , 2017 .

[20]  J. Meeker,et al.  Relationships Between Urinary Phthalate Metabolite and Bisphenol A Concentrations and Vitamin D Levels in U.S. Adults: National Health and Nutrition Examination Survey (NHANES), 2005-2010. , 2016, The Journal of clinical endocrinology and metabolism.

[21]  J. Koponen,et al.  Effects of developmental exposure to perfluorooctanoic acid (PFOA) on long bone morphology and bone cell differentiation. , 2016, Toxicology and applied pharmacology.

[22]  M. Lopez-Espinosa,et al.  Perfluoroalkyl Substances, Sex Hormones, and Insulin-like Growth Factor-1 at 6–9 Years of Age: A Cross-Sectional Analysis within the C8 Health Project , 2016, Environmental health perspectives.

[23]  K. Kannan,et al.  Association of Perfluoroalkyl Substances, Bone Mineral Density, and Osteoporosis in the U.S. Population in NHANES 2009–2010 , 2015, Environmental health perspectives.

[24]  J. Meeker,et al.  Serum Biomarkers of Exposure to Perfluoroalkyl Substances in Relation to Serum Testosterone and Measures of Thyroid Function among Adults and Adolescents from NHANES 2011–2012 , 2015, International journal of environmental research and public health.

[25]  B. Cheung,et al.  Inorganic and organic mercury levels in the United States National Health and Nutrition Examination Survey (NHANES) 2005-2010 , 2015 .

[26]  A. Shankar,et al.  The association between PFOA, PFOS and serum lipid levels in adolescents. , 2014, Chemosphere.

[27]  Pau-Chung Chen,et al.  Negative association between serum perfluorooctane sulfate concentration and bone mineral density in US premenopausal women: NHANES, 2005-2008. , 2014, The Journal of clinical endocrinology and metabolism.

[28]  Damià Barceló,et al.  Accumulation of perfluoroalkyl substances in human tissues. , 2013, Environment international.

[29]  Andrzej Kolinski,et al.  CABS-flex: server for fast simulation of protein structure fluctuations , 2013, Nucleic Acids Res..

[30]  B. An,et al.  Effects of octylphenol and bisphenol A on the expression of calcium transport genes in the mouse duodenum and kidney during pregnancy. , 2013, Toxicology.

[31]  Yu Gao,et al.  Assessment of estrogenic activity of perfluoroalkyl acids based on ligand-induced conformation state of human estrogen receptor. , 2013, Environmental science & technology.

[32]  S. Peltier,et al.  Vitamin D metabolism, functions and needs: from science to health claims , 2013, European Journal of Nutrition.

[33]  Glenville Jones,et al.  25-Hydroxyvitamin D-24-hydroxylase (CYP24A1): its important role in the degradation of vitamin D. , 2012, Archives of biochemistry and biophysics.

[34]  H. Anderson,et al.  Effect of 25‐hydroxyvitamin D3 and 1 α,25 dihydroxyvitamin D3 on differentiation and apoptosis of human osteosarcoma cell lines , 2012, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[35]  C. Foresta,et al.  Profiling Insulin Like Factor 3 (INSL3) Signaling in Human Osteoblasts , 2011, PloS one.

[36]  A. Bergman,et al.  Tissue distribution of ³⁵S-labelled perfluorooctane sulfonate in adult mice after oral exposure to a low environmentally relevant dose or a high experimental dose. , 2011, Toxicology.

[37]  William H. Bisson,et al.  Estrogen-like activity of perfluoroalkyl acids in vivo and interaction with human and rainbow trout estrogen receptors in vitro. , 2011, Toxicological sciences : an official journal of the Society of Toxicology.

[38]  M. Weinstock,et al.  Factors influencing vitamin D status. , 2011, Acta dermato-venereologica.

[39]  G. Strapazzon,et al.  Bone mineral density and testicular failure: evidence for a role of vitamin D 25-hydroxylase in human testis. , 2011, The Journal of clinical endocrinology and metabolism.

[40]  Y. Tan,et al.  Perfluorooctanoic acid effects on steroid hormone and growth factor levels mediate stimulation of peripubertal mammary gland development in C57BL/6 mice. , 2010, Toxicological sciences : an official journal of the Society of Toxicology.

[41]  T. Webster,et al.  Exposure to Polyfluoroalkyl Chemicals and Cholesterol, Body Weight, and Insulin Resistance in the General U.S. Population , 2009, Environmental health perspectives.

[42]  Arthur J. Olson,et al.  AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading , 2009, J. Comput. Chem..

[43]  Kyung-Chul Choi,et al.  Compensatory induction of the TRPV6 channel in a calbindin‐D9k knockout mouse: Its regulation by 1,25‐hydroxyvitamin D3 , 2009, Journal of cellular biochemistry.

[44]  Keehyoung Joo,et al.  Improving physical realism, stereochemistry, and side‐chain accuracy in homology modeling: Four approaches that performed well in CASP8 , 2009, Proteins.

[45]  Yu-Chuan Lin,et al.  Association Among Serum Perfluoroalkyl Chemicals, Glucose Homeostasis, and Metabolic Syndrome in Adolescents and Adults , 2008, Diabetes Care.

[46]  Robert A Hoke,et al.  Are PFCAs bioaccumulative? A critical review and comparison with regulatory criteria and persistent lipophilic compounds. , 2008, Environmental science & technology.

[47]  C. Lau,et al.  Perfluoroalkyl acids: a review of monitoring and toxicological findings. , 2007, Toxicological sciences : an official journal of the Society of Toxicology.

[48]  Wei Wu,et al.  1alpha,25-Dihydroxyvitamin D(3) antiproliferative actions involve vitamin D receptor-mediated activation of MAPK pathways and AP-1/p21(waf1) upregulation in human osteosarcoma. , 2007, Cancer letters.

[49]  A. Zannettino,et al.  Metabolism of vitamin D3 in human osteoblasts: evidence for autocrine and paracrine activities of 1 alpha,25-dihydroxyvitamin D3. , 2007, Bone.

[50]  D. Moras,et al.  Adaptability of the Vitamin D nuclear receptor to the synthetic ligand Gemini: Remodelling the LBP with one side chain rotation , 2007, The Journal of Steroid Biochemistry and Molecular Biology.

[51]  Ji-Bin Peng,et al.  1,25–Dihydroxyvitamin D and 25–hydroxyvitamin D—mediated regulation of TRPV6 (a putative epithelial calcium channel) mRNA expression in Caco–2 cells , 2006, European journal of nutrition.

[52]  M. Burns,et al.  Case-Control Study , 2020, Definitions.

[53]  D. Miao,et al.  Inactivation of the 25-Hydroxyvitamin D 1α-Hydroxylase and Vitamin D Receptor Demonstrates Independent and Interdependent Effects of Calcium and Vitamin D on Skeletal and Mineral Homeostasis* , 2004, Journal of Biological Chemistry.

[54]  M. D. C. Ruiz de Villa,et al.  [Repeated measures analysis]. , 2004, Medicina clinica.

[55]  M. Thomasset,et al.  Vitamin-D-dependent calcium-binding protein (CaBP-9K) in rat growth cartilage , 2004, Histochemistry.

[56]  M. Hediger,et al.  Calcium transporter 1 and epithelial calcium channel messenger ribonucleic acid are differentially regulated by 1,25 dihydroxyvitamin D3 in the intestine and kidney of mice. , 2003, Endocrinology.

[57]  M. Sitrin,et al.  Effects of vitamin D receptor inactivation on the expression of calbindins and calcium metabolism. , 2001, American journal of physiology. Endocrinology and metabolism.

[58]  P. Lips,et al.  Vitamin D deficiency and secondary hyperparathyroidism in the elderly: consequences for bone loss and fractures and therapeutic implications. , 2001, Endocrine reviews.

[59]  D. Moras,et al.  Crystal structures of the vitamin D receptor complexed to superagonist 20-epi ligands , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[60]  S. Kato,et al.  Transcriptional activation of p21 by vitamin D(3) or vitamin K(2) leads to differentiation of p53-deficient MG-63 osteosarcoma cells. , 2001, Human pathology.

[61]  C. Baird,et al.  The pilot study. , 2000, Orthopedic nursing.

[62]  P. Mäenpää,et al.  Inhibition of proliferation and induction of differentiation of osteoblastic cells by a novel 1,25‐dihydroxyvitamin D3 analog with an extensively modified side chain (CB1093) , 1998, Journal of cellular biochemistry.

[63]  T. Sakai,et al.  p53-independent induction of WAF1/Cip1 is correlated with osteoblastic differentiation by vitamin D3. , 1998, Cancer letters.

[64]  C. Devlin,et al.  The effects of dexamethasone and 1,25-dihydroxyvitamin D3 on osteogenic differentiation of human marrow stromal cells in vitro. , 1994, Archives of oral biology.

[65]  R. Wood,et al.  Identification of calbindin D-9k mRNA and its regulation by 1,25-dihydroxyvitamin D3 in Caco-2 cells. , 1994, Archives of biochemistry and biophysics.